You are here

QT Vascular assures investors over suit

CEO: Minimal probability of a permanent injunction against its Chocolate PTA balloon catheter


QT VASCULAR has assured investors in an update on the ongoing litigation involving specialty balloon angioplasty company AngioScore Inc during its annual general meeting on Thursday last week.

In June 2012, AngioScore initiated patent infringement proceedings against QT

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom